Citation Impact
Citing Papers
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Long-Term Outcome and its Predictors in Giant Cell Myocarditis
2016
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
2020
Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes
2018
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Synapses and Alzheimer's Disease
2012 StandoutNobel
Attenuation of Meal-Induced Inflammatory and Thrombotic Responses in Overweight Men and Women After 6-Week Daily Strawberry (Fragaria) Intake
2011
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)
2015
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery diseasew
2007
Cardiac Sarcoidosis
2016
Thiazolidinediones and PPARγ agonists: time for a reassessment
2012
Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
2011
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
The Associations between Various Ectopic Visceral Adiposity and Body Surface Electrocardiographic Alterations: Potential Differences between Local and Remote Systemic Effects
2016
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Thiazolidinediones and the liver in humans
2009
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring
2017
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
The Role of Apolipoprotein E in Alzheimer's Disease
2009
Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance
2018
Cardiac PET Imaging for the Detection and Monitoring of Coronary Artery Disease and Microvascular Health
2010
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure
2017
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Cardiac Sarcoidosis
2014
Bioactive Compounds and Antioxidant Activity in Different Types of Berries
2015 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression
2012
Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)
2010
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
2020
Works of Marit Granér being referenced
Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
2018
Cardiac steatosis and left ventricular function in men with metabolic syndrome
2013
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease
2007
Impact of postprandial lipaemia on low‐density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease
2006
Pulmonary embolism location is associated with the co-existence of the deep venous thrombosis
2019
Association of Carotid Intima-Media Thickness With Angiographic Severity and Extent of Coronary Artery Disease
2006
Diagnosing isolated cardiac sarcoidosis
2011
Electrocardiographic changes associated with insulin resistance
2013
Cardiac Steatosis Associates With Visceral Obesity in Nondiabetic Obese Men
2013
Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses
2007
Ectopic Fat Depots and Left Ventricular Function in Nondiabetic Men With Nonalcoholic Fatty Liver Disease
2014